{"denoms":[{"counts":[{"groupId":"BG000","value":"137"}],"units":"Participants"}],"groups":[{"description":"All subjects were males with advanced prostate carcinoma. They were injected twice with a depot formulation containing 50 mg of Leuprolide Mesylate. The first dose on day 0 the second dose on day 168 (six months apart). Subjects were followed until day 336.\n\nLeuprolide Mesylate: Subcutaneous injection of 50mg Leuprolide Mesylate","id":"BG000","title":"Leuprolide Mesylate 50mg"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.70","value":"71.1"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"137"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"61"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"73"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"5"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"8"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"123"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Austria"},{"categories":[{"measurements":[{"groupId":"BG000","value":"64"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"}]}],"title":"Czechia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Taiwan"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"Poland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"18"}]}],"title":"Slovakia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"29"}]}],"title":"Lithuania"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Germany"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}]}